CVE-2026-123218: IBM Aspera Faspex Incorrect Authorization Vulnerability
What it is
You may face significant business disruption and potential data breaches if an attacker exploits the incorrect authorization vulnerability in IBM Aspera Faspex to gain elevated privileges. You should update to the vendor's fixed version as soon as possible to prevent unauthorized access and privilege escalations.
CISA: IBM Aspera Faspex contains an incorrect authorization vulnerability that could allow an authenticated user to craft a specific message to bypass authorization, causing privilege escalations.
What to do
Treat this as urgent. Identify every affected system, starting with anything internet-facing, and apply the vendor fix or mitigation within days. If you cannot patch quickly, isolate or disable the affected service and watch for signs of compromise.
- Priority
- Act now: Patch or mitigate internet-facing systems within days.
- Severity (CVSS)
- 9.8 critical
- CISA assessment (SSVC)
- actively exploited; attackers can automate it at scale; total control of the affected system
- Exploit probability (EPSS, 30 days)
- 0.5%, higher than 45% of all CVEs
- Added to CISA KEV
- 9 November 2026
- CISA fix-by date
- 12 November 2026 (US federal agencies; a sensible deadline for everyone)
- Ransomware use
- Not known
- Weakness
- CWE-863
References
- NIST NVD entry
- CISA KEV entry
- www.ibm.com/support/pages/node/7295921
- www.cisa.gov/known-exploited-vulnerabilities-catalog?field_cve=CVE-2026-123218
Sources: CISA Known Exploited Vulnerabilities · FIRST Exploit Prediction Scoring System (EPSS) · NIST National Vulnerability Database · CISA Vulnrichment (SSVC), via the CVE Program. This product uses data from the NVD API but is not endorsed or certified by the NVD. Summaries are machine-written from CISA’s description; treat the vendor’s advisory as the authority for fixes.